1. Home
  2. Knowledge Base
  3. References
  4. CXB-909 attenuates cognitive deficits in the mu-p-75 saporin mouse model of Alzheimer’s disease.

CXB-909 attenuates cognitive deficits in the mu-p-75 saporin mouse model of Alzheimer’s disease.

Lowrance S, Matchynski J, Rossignol J, Dekorver N, Sandstrom M, Dunbar G (2012) CXB-909 attenuates cognitive deficits in the mu-p-75 saporin mouse model of Alzheimer’s disease. Neuroscience & Medicine 3(1):65-68. doi: 10.4236/nm.2012.31010

Summary: CXB-909 is a small molecule NGF amplifier that has been shown to enhance neurite outgrowth in various neuronal cell lines. This type of molecule has potential therapeutic use in disorders such as Alzheimer’s disease. In this work the authors lesioned cholinergic cells in the basal forebrain of mice with bilateral 0.8 μg intracerebroventricular injections of mup75-SAP (Cat. #IT-16). Lesioned animals performed significantly worse than controls in a water maze task. Lesioned animals subsequently treated with CXB-909 displayed improved performance, indicating that CXB-909 can attenuate memory deficits caused by loss of cholinergic input.

Related Products: mu p75-SAP (Cat. #IT-16)